Despite the remarkable progress in the oncology molecular diagnostics market, the Asia-Pacific region faces several challenges, including regulatory complexities, reimbursement issues, and the lack of standardized guidelines for the implementation of molecular diagnostic tests. Addressing these challenges requires collaborative efforts from regulatory bodies, healthcare organizations, and industry stakeholders to establish robust regulatory frameworks and ensure the accessibility and affordability of molecular diagnostic technologies for all segments of the population.
Know More- https://www.alliedmarketresearch.com/asia-pacific-oncology-molecular-diagnostics-market-A06287